Therefore, based on meta-analyses data, there is an association of increased ADAM17 expression in a number of tumor types, including GC, with the poor OS, TNM stage and lymph node metastasis. Here, ADAM17 is linked to metastatic malignant neoplasm in the lymph nodes.